Clinical Trial Update: rtPA in in the Prevention of CVAD-Associated Thrombosis and Infection in Pediatric Patients With Short Bowel Syndrome [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating rtPA for prevention of central venous access device (CVAD) thrombosis and infection in pediatric patients with short bo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Short Bowel Syndrome

Drugs mentioned

• rtPA (tissue plasminogen activator)

Snippet

Sponsor: Lynn Malec | Conditions: Short Bowel Syndrome | Phase 4 | Status: COMPLETED | Results posted: 2018-02-06